DZ2291A1 - Cellule immortelle pour l'accroissement des virus. - Google Patents

Cellule immortelle pour l'accroissement des virus.

Info

Publication number
DZ2291A1
DZ2291A1 DZ970141A DZ970141A DZ2291A1 DZ 2291 A1 DZ2291 A1 DZ 2291A1 DZ 970141 A DZ970141 A DZ 970141A DZ 970141 A DZ970141 A DZ 970141A DZ 2291 A1 DZ2291 A1 DZ 2291A1
Authority
DZ
Algeria
Prior art keywords
viruses
growth
immortal cell
immortal
cell
Prior art date
Application number
DZ970141A
Other languages
English (en)
Inventor
Douglas N Foster
Linda K Forster
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of DZ2291A1 publication Critical patent/DZ2291A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DZ970141A 1996-08-13 1997-08-13 Cellule immortelle pour l'accroissement des virus. DZ2291A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth

Publications (1)

Publication Number Publication Date
DZ2291A1 true DZ2291A1 (fr) 2002-12-25

Family

ID=24796108

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970141A DZ2291A1 (fr) 1996-08-13 1997-08-13 Cellule immortelle pour l'accroissement des virus.

Country Status (28)

Country Link
US (4) US5672485A (fr)
EP (1) EP0920491B1 (fr)
JP (3) JP3754088B2 (fr)
KR (1) KR100375871B1 (fr)
CN (1) CN1228119B (fr)
AR (1) AR008294A1 (fr)
AT (1) ATE362524T1 (fr)
AU (1) AU726820B2 (fr)
BR (1) BR9711067A (fr)
CA (1) CA2263725C (fr)
CO (1) CO4700552A1 (fr)
DE (1) DE69737735T2 (fr)
DK (1) DK0920491T3 (fr)
DZ (1) DZ2291A1 (fr)
ES (1) ES2285738T3 (fr)
GT (1) GT199700091A (fr)
HN (1) HN1997000124A (fr)
HU (1) HU226658B1 (fr)
IL (4) IL158302A0 (fr)
MA (1) MA24303A1 (fr)
MY (1) MY125594A (fr)
NZ (1) NZ334147A (fr)
PE (1) PE108198A1 (fr)
PT (1) PT920491E (fr)
SV (1) SV1997000071A (fr)
UY (1) UY24668A1 (fr)
WO (1) WO1998006824A1 (fr)
ZA (1) ZA977216B (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) * 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
WO2004031450A1 (fr) * 2002-09-30 2004-04-15 Honda Giken Kogyo Kabushiki Kaisha Appareil activateur d'hydrogene
CA2510229A1 (fr) * 2002-12-13 2004-07-08 Aventis Pasteur, Inc. Production du virus alvac sur des cellules souches embryonnaires d'oiseaux
US20060294604A1 (en) * 2003-02-17 2006-12-28 Fridman Jordan S Model for studying the role of genes in tumor resistance to chemotherapy
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
WO2004080162A2 (fr) * 2003-03-07 2004-09-23 Avigenics, Inc. Transgenese aviaire mediee par integrase
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
PT1646715E (pt) 2003-07-22 2010-08-09 Vivalis Produção de poxvírus com linhagem das células aviarias aderentes ou não aderentes
WO2005028634A2 (fr) * 2003-09-18 2005-03-31 Emory University Vaccins mva ameliores
EP1528101A1 (fr) 2003-11-03 2005-05-04 ProBioGen AG Lignées cellulaires aviaires immortalisées pour la production de virus
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
WO2006042214A1 (fr) * 2004-10-08 2006-04-20 Avigenics, Inc. Integrase modifiee et procedes d'utilisation
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CA2610265A1 (fr) * 2005-05-31 2007-05-10 Cold Spring Harbor Laboratory Methode de production de micro-arns
TR201909425T4 (tr) 2005-10-05 2019-07-22 Alexion Pharma Inc Yüksek ti̇treli̇ vi̇rüsün hizli üreti̇mi̇
ES2611975T3 (es) 2006-06-20 2017-05-11 Transgene S.A. Procedimiento para producir poxvirus y composiciones de poxvirus
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (fr) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes contenant de l'hémagglutinine dérivée du virus de la grippe produit par les lignées cellulaires; les compositions, les méthodes de production, l'emploi des virosomes
US8361788B2 (en) * 2007-07-03 2013-01-29 Transgene S.A. Immortalized avian cell lines comprising E1A nucleic acid sequences
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
US8901288B2 (en) * 2007-10-26 2014-12-02 Cold Spring Harbor Laboratory High throughput methods for functionally determining RNA interference efficiency
KR20140096162A (ko) * 2008-02-25 2014-08-04 백스터 인터내셔널 인코포레이티드 연속 세포주 제조 방법
NZ596595A (en) * 2009-05-12 2013-05-31 Transgene Sa Method for orthopoxvirus production and purification
WO2010144797A2 (fr) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Vaccins contre la grippe avec immunogénicité accrue et leurs utilisations
WO2012010280A1 (fr) 2010-07-20 2012-01-26 Bavarian Nordic A/S Procédé pour collecter des produits d'expression
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
AU2015357225B2 (en) 2014-12-01 2020-04-09 Transgene Sa Stable liquid vaccinia virus formulations
JP6546659B2 (ja) * 2014-12-04 2019-07-17 インターベット インターナショナル ベー． フェー． 不死化ニワトリ胚線維芽細胞
ES3011733T3 (en) 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
EP3452081A1 (fr) 2016-05-04 2019-03-13 Transgene SA Polythérapie avec un ligand de tlr9 cpg
IL302693B2 (en) * 2016-07-11 2025-10-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Methods and systems for growing cells in culture
EP3522920A2 (fr) 2016-10-10 2019-08-14 Transgene SA Polythérapie à base d'un produit immunothérapeutique et de modulateurs de mdsc
US20200179507A1 (en) 2016-11-17 2020-06-11 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
CA3061678A1 (fr) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Composition contenant un virus stable
US11052147B2 (en) 2017-05-15 2021-07-06 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
JP7334124B2 (ja) 2017-06-21 2023-08-28 トランジェーヌ 個別化ワクチン
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
EP3847246A1 (fr) 2018-09-06 2021-07-14 Bavarian Nordic A/S Compositions de poxvirus améliorées en matière de stockage
US12478571B2 (en) 2018-12-17 2025-11-25 Pontis Biologics, Inc. Enzyme based compositions and methods for removing dental calculi
MX2022007579A (es) 2019-12-20 2022-07-19 Intervet Int Bv Vacuna de vector hvt multivalente.
WO2021180943A1 (fr) 2020-03-12 2021-09-16 Bavarian Nordic A/S Compositions améliorant la stabilité du poxvirus
CN116322740A (zh) 2020-07-13 2023-06-23 特兰斯吉恩股份有限公司 免疫抑制的治疗
EP4210740A1 (fr) 2020-09-07 2023-07-19 Intervet International B.V. Vaccin à souche ha pour cibles positives aux anticorps ha
WO2022136623A1 (fr) 2020-12-24 2022-06-30 Intervet International B.V. Vaccin à vecteur hvt multivalent
EP4370150A1 (fr) 2021-07-13 2024-05-22 Intervet International B.V. Surmonter l'interférence d'anticorps chez les oiseaux
WO2023213764A1 (fr) 2022-05-02 2023-11-09 Transgene Polypeptide de fusion comprenant un anti-pd-l1 sdab et un membre du tnfsf
WO2023213763A1 (fr) 2022-05-02 2023-11-09 Transgene Poxvirus codant pour un agent de liaison comprenant un sdab anti-pd-l1
US20250352642A1 (en) 2022-05-05 2025-11-20 Intervet Inc. New multivalent hvt vector vaccine
WO2025074921A1 (fr) * 2023-10-06 2025-04-10 株式会社微生物化学研究所 Procédé de production de virus
CN121006317B (zh) * 2025-10-22 2026-02-06 海南大学三亚南繁研究院 一种永生化鸡胚肾上皮样细胞及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
CA2263725C (fr) 2002-10-15
CN1228119A (zh) 1999-09-08
ZA977216B (en) 1998-02-19
DE69737735D1 (de) 2007-06-28
KR100375871B1 (ko) 2003-03-10
JP2006320328A (ja) 2006-11-30
EP0920491A1 (fr) 1999-06-09
CN1228119B (zh) 2012-04-04
GT199700091A (es) 1997-08-12
US5672485A (en) 1997-09-30
HUP0000188A2 (hu) 2000-06-28
MY125594A (en) 2006-08-30
US5879924A (en) 1999-03-09
ATE362524T1 (de) 2007-06-15
HUP0000188A3 (en) 2005-11-28
HN1997000124A (es) 1999-03-19
PE108198A1 (es) 1999-01-21
DK0920491T3 (da) 2007-09-17
IL158303A0 (en) 2004-05-12
JP2000516095A (ja) 2000-12-05
CO4700552A1 (es) 1998-12-29
AU726820B2 (en) 2000-11-23
US6207415B1 (en) 2001-03-27
SV1997000071A (es) 2000-07-06
HU226658B1 (en) 2009-06-29
MA24303A1 (fr) 1998-04-01
PT920491E (pt) 2007-07-27
EP0920491B1 (fr) 2007-05-16
IL128511A0 (en) 2000-01-31
CA2263725A1 (fr) 1998-02-19
DE69737735T2 (de) 2008-01-31
IL128511A (en) 2004-06-01
NZ334147A (en) 2000-08-25
WO1998006824A1 (fr) 1998-02-19
KR20000029968A (ko) 2000-05-25
JP2005118053A (ja) 2005-05-12
IL158302A0 (en) 2004-05-12
JP3754088B2 (ja) 2006-03-08
ES2285738T3 (es) 2007-11-16
HK1022496A1 (en) 2000-08-11
AU4069197A (en) 1998-03-06
US5985642A (en) 1999-11-16
BR9711067A (pt) 1999-08-17
AR008294A1 (es) 1999-12-29
UY24668A1 (es) 1998-02-02
IL158301A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
MA24303A1 (fr) Lignes cellulaires immortalisees pour la croissance du virus.
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR2694182B1 (fr) Attache pour prothèse, notamment interpédiculaire.
EP0859547A4 (fr) Enrobages rendant les virus inactifs
FR2740231B1 (fr) Ebauche pour oculaire non-correcteur
EP1052988A4 (fr) Procedes et compositions utiles pour inactiver des virus
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
FI972030A7 (fi) Puhdistettuja papillomavirusproteiineja
FR2729535B1 (fr) Housse pour la culture notamment des bananes
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
IT1313185B1 (it) Gruppo di chiusura di estremita'.
FR2668337B1 (fr) Etrogneuse pour vegetaux du type brocolis.
TR199700605A3 (tr) Kopolieterester ' den mamul eriyerek yapisan cisimler.
DZ3018A1 (fr) Procédés perfectionnés pour la préparation sécrétagogues d'hormones de croissance.
EP1142996A4 (fr) Anticorps monoclonal dirige contre l'apolipoproteine a-1
FR2702506B1 (fr) Plot réglable de support de dalles.
AU6551800A (en) Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
BR9506962A (pt) Cultura seletiva de virus
FR2734988B1 (fr) Conteneur pour l'arboriculture
KR970006515A (ko) 진공정련용 레이들의 뚜껑
MA24078A1 (fr) Procede pour l'utilisation de derives de tetrahydroisoquinoleine
FR2699045B1 (fr) Récipient pour plantes.
DE69302611D1 (de) Mehrschariger Pflug
FR2742417B1 (fr) Recipient metallique du type boite-boisson
FR2721234B1 (fr) Broyeurs pour grandes cultures.